Riggs Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Riggs Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,700	Closed	-$253K	–	335
2022 Q3	$253K	Buy	+7,700	New	+$283K	0.1%	85
2021 Q4	–	Sell	-5,541	Closed	-$414K	–	319
2021 Q3	$414K	Buy	5,541 +54	+1%	+$4.53K	0.12%	72
2021 Q2	$508K	Buy	5,487 +259	+5%	+$22K	0.14%	66
2021 Q1	$464K	Sell	5,228 -195	-4%	-$19.3K	0.14%	67
2020 Q4	$506K	Buy	+5,423	New	+$432K	0.16%	61

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Riggs Asset Management's ARKG Position: Q4 2022 in Review

Riggs Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 7,700 shares — an estimated $253K sold.

Riggs Asset Management first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $508K in Q2 2021. 321 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Riggs Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
Riggs Asset Management sold 7,700 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $253K.
Riggs Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
Riggs Asset Management's ARK Genomic Revolution ETF position peaked at $508K in Q2 2021.
321 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Riggs Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.